Showing results (331-340 of 9,974) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|December 1, 2011
Investigation and analysis of single nucleotide polymorphisms in Janus kinase/signal transducer and activator of transcription genes with leukemiaYuejiao Zhong, Jianzhong Wu, Baoan Chen, et al.Leukemia & Lymphoma|December 6, 2011
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplantJenna D Goldberg, Joanne F Chou, Steven Horwitz, et al.Leukemia & Lymphoma|December 3, 2011
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplantAndrew A Lane, Philippe Armand, Yang Feng, et al.Leukemia & Lymphoma|September 30, 2011
Leptin promoter G-2548A genotypes and associated serum leptin levels in childhood acute leukemia at diagnosis and under high-dose steroid therapyBetul Tavil, Gunay Balta, Eser Lay Ergun, et al.Leukemia & Lymphoma|November 10, 2011
LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab eraJames R Cerhan, Yasodha Natkunam, Lindsay M Morton, et al.Leukemia & Lymphoma|November 1, 2011
High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisoneKazuhito Suzuki, Yasuhito Terui, Kenji Nakano, et al.Leukemia & Lymphoma|November 1, 2011
The T_T genotype within the NME1 promoter single nucleotide polymorphism -835 C/T is associated with an increased risk of cytarabine induced neurotoxicity in patients with acute myeloid leukemiaDominic Braunagel, Markus Schaich, Michael Kramer, et al.Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.Leukemia & Lymphoma|June 27, 2009
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trialAzra Raza, Joseph G Jurcic, Gail J Roboz, et al.Leukemia & Lymphoma|June 27, 2009
Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamideAnn-Sofie Johansson, Sven-Christian Pawelzik, Asa Larefalk, et al.Pageof 998